Furthermore, the activation of JAK2/STAT3 favors proliferation and motility of breast cancer cells by different mechanisms, including the suppression of apoptosis by upregulation of cyclin D-1, c-Myc, and Bcl-2, and promotion of EMT. Here, STAT3 is linked to breast carcinoma.